# EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors

> **NCT05566093** · NA · UNKNOWN · sponsor: **Guangxi Medical University** · enrollment: 20 (estimated)

## Conditions studied

- Nonfunctional Pancreatic Neuroendocrine Tumor
- Pancreatic Neuroendocrine Tumor
- Endoscopic Ultrasound

## Interventions

- **PROCEDURE:** EUS-guided ethanol ablation
- **PROCEDURE:** EUS-guided lauromacrogol ablation

## Key facts

- **NCT ID:** NCT05566093
- **Lead sponsor:** Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-28
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05566093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05566093, "EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05566093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*